-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QaxuQQ/EKAXqHxwQXwyVIR9RkNvAnbMvC5dlT92cnkPvdvhx9DnIuCwSAa5LQ0H7 G0ioZKwWdnzgx6zitxsDhg== 0001209191-08-002356.txt : 20080107 0001209191-08-002356.hdr.sgml : 20080107 20080107153552 ACCESSION NUMBER: 0001209191-08-002356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071228 FILED AS OF DATE: 20080107 DATE AS OF CHANGE: 20080107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoCore Inc CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC DATE OF NAME CHANGE: 20011009 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 FORMER COMPANY: FORMER CONFORMED NAME: BELL NATIONAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCULLOGH ROBERT F JR CENTRAL INDEX KEY: 0001341597 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00935 FILM NUMBER: 08515020 BUSINESS ADDRESS: BUSINESS PHONE: 415 398 0154 MAIL ADDRESS: STREET 1: P.O. BOX 151 CITY: KENTFIELD STATE: CA ZIP: 94914 4 1 c22769_01rfm.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-12-28 0000075439 CytoCore Inc CYOE.OB 0001341597 MCCULLOGH ROBERT F JR C/O CYTOCORE, INC. 414 N. ORLEANS STREET, SUITE 502 CHICAGO IL 60610 1 1 0 0 CEO & CFO Common Stock, $0.001 par value 2007-12-28 4 P 0 7500 2.3 A 410750 I See footnote. Common Stock, $0.001 par value 103705 I See footnote . Common Stock, $0.001 par value 202417 D Securities purchased by Summitcrest Capital L.P., of which the Reporting Person is the President of the General Partner. Owned by the MPC Trust, of which the Reporting Person is a trustee. /s/ Robert F. McCollough 2008-01-07 -----END PRIVACY-ENHANCED MESSAGE-----